#mounjaro

Novo Nordisk Price Cuts Expected to Reshape India GLP-1 Market

Analysts expect Novo's aggressive cuts to capture the lion's share of India's GLP-1 market in 12-18 months. Eli Lilly's Mounjaro currently dominates with ~79% share vs Novo's ~21%.